1.
Regulatory T cell proliferative potential is impaired in human autoimmune disease
by Carbone, Fortunata
Nature medicine, 2014, Vol.20 (1), p.69-74
2.
Impaired natural killer cell functions in patients with signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations
by Tabellini, Giovanna, PhD
Journal of allergy and clinical immunology, 2017, Vol.140 (2), p.553-564.e4
3.
Cytokine Gene Polymorphisms and Human Autoimmune Disease in the Era of Genome-Wide Association Studies
by Vandenbroeck, Koen
Journal of interferon & cytokine research, 2012, Vol.32 (4), p.139-151
4.
T+ NK+ IL-2 Receptor γ Chain Mutation: a Challenging Diagnosis of Atypical Severe Combined Immunodeficiency
by Stepensky, Polina
Journal of clinical immunology, 2018, Vol.38 (4), p.527-536
5.
Roles of LAG3 and EGR2 in regulatory T cells
by Okamura, Tomohisa
Annals of the Rheumatic Diseases, 2012, Vol.71 (Suppl 2), p.i96-i100
6.
Structure and Function of an Inflammatory Cytokine, Interleukin-2, Analyzed Using the Bioinformatic Approach
by Roy, Urmi
The Protein Journal, 2019, Vol.38 (5), p.525-536
7.
Teriflunomide inhibits activation-induced CD25 expression on T cells and may affect Foxp3-expressing regulatory T cells
by Jasiecka-Mikołajczyk, Agnieszka
Research in veterinary science, 2020, Vol.132, p.17-27
8.
Pathogenesis of multiple sclerosis via environmental and genetic dysregulation of N-glycosylation
by Grigorian, Ani
Seminars in immunopathology, 2012, Vol.34 (3), p.415-424
9.
Acute Exposure to 50-Hz Magnetic Fields Increases Interleukin-6 in Young Healthy Men
by Selmaoui, Brahim
Journal of clinical immunology, 2011, Vol.31 (6), p.1105-1111
10.
Cytokines in the Treatment of Cancer
by Conlon, Kevin C.
Journal of interferon & cytokine research, 2019, Vol.39 (1), p.6-21
11.
PTU-070 Fine mapping of the IL-2/IL-21 and IL2RA loci in primary sclerosing cholangitis
by Srivastava, B
Gut, 2012, Vol.61 (Suppl 2), p.A212
12.
Moderate consumption of a soluble green/roasted coffee rich in caffeoylquinic acids reduces cardiovascular risk markers: results from a randomized, cross-over, controlled trial in...
by Martínez-López, Sara
European journal of nutrition, 2018, Vol.58 (2), p.865-878
13.
PMO-255 The expression of interleukin 2 receptor in intestinal resection specimens from patients with Crohn's disease as assessed by immunohistochemistry
by Russo, E
Gut, 2012, Vol.61 (Suppl 2), p.A179-A179
14.
ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial
by Wrangle, John M
The lancet oncology, 2018, Vol.19 (5), p.694-704
15.
Self-assembling protein nanoparticles with built-in flagellin domains increases protective efficacy of a Plasmodium falciparum based vaccine
by Kaba, Stephen A
Vaccine, 2018, Vol.36 (6), p.906-914
16.
Low-dose IL-2 therapy limits the reduction in absolute numbers of peripheral lymphocytes in systemic lupus erythematosus patients with infection
by Zhang, Jia-Qian
Current medical research and opinion, 2022, Vol.38 (6), p.1037-1044
17.
Cytokine release syndrome in a patient with colorectal cancer after vaccination with BNT162b2
by Au, Lewis
Nature medicine, 2021, Vol.27 (8), p.1362-1366
18.
Restoring cytokine balance in HIV Positive Individuals with Low CD4 T Cell Counts
by Valdivia, Anddre
AIDS research and human retroviruses, 2017, Vol.33 (ja), p.905-918
19.
A novel chimeric antigen receptor containing a JAK-STAT signaling domain mediates superior antitumor effects
by Kagoya, Yuki
Nature medicine, 2018, Vol.24 (3), p.352-359
20.
Recombinant bovine IL17A acts as an adjuvant for bovine herpesvirus vaccine
by Gonçalves, Vitória Sequeira
Research in veterinary science, 2021, Vol.136, p.185-191
